Loading field map
Every health system must answer a deceptively simple question: how to raise enough money for health care, pool it to spread risk, and allocate it to services in ways that are both efficient and fair. The answers have varied dramatically across countries and eras, and the subfield of health financing emerged to study these choices systematically. Its history is a story of competing models—each with distinct assumptions about the role of the state, the market, and communities—and of ongoing efforts to reconcile equity with sustainability.
The earliest systematic approach to financing health in low- and middle-income countries was not designed to build health systems at all. Colonial administrations and later international agencies funded disease-specific campaigns—against malaria, smallpox, yaws, or sleeping sickness—through short-term, project-based grants. This Vertical Disease Control Financing model allocated resources to single interventions, often delivered by dedicated staff and supply chains outside the general health system. Its strength was clear accountability and measurable results for a targeted disease. Its weakness was equally clear: it left little behind in the way of permanent infrastructure, local capacity, or financial protection for patients. By the 1970s, critics argued that vertical financing had created a patchwork of parallel programs that fragmented care and ignored the underlying weakness of health systems.
In response to the limitations of vertical funding, two comprehensive models emerged in the 1970s and 1980s, each proposing a different way to organize the entire financing system. Tax-Based Financing (also called the Beveridge model) funds health care from general government revenue. The state collects taxes and directly pays providers, often owning hospitals and employing staff. The United Kingdom, Sweden, and many Commonwealth countries adopted this model. Its central commitment is universal coverage financed by progressive taxation, with the state as both payer and provider. Social Health Insurance (the Bismarck model), by contrast, ties funding to payroll contributions from employers and employees, channeled through non-governmental sickness funds. Germany, Japan, and many European and Latin American countries followed this path. Its logic is solidarity within a defined pool of contributors, with contributions proportional to income and access independent of risk.
These two frameworks were not merely technical alternatives; they embodied different political philosophies about the state's role. Tax-based advocates argued that only general revenue could achieve truly universal coverage, since payroll-based systems exclude informal workers and the unemployed. Social insurance proponents countered that earmarked contributions create a stable funding stream and a sense of entitlement that protects health budgets from political cuts. The debate was never fully resolved. Instead, many countries developed hybrid systems—using tax revenue to subsidize coverage for the poor within a social insurance framework, or supplementing tax-funded care with mandatory insurance for specific groups.
By the 1980s, it was clear that neither tax-based nor social insurance models could be easily transplanted to low-income countries with large informal economies and weak state capacity. Two additional frameworks were proposed as alternatives. Community-Based Health Insurance (CBHI) emerged in rural areas of sub-Saharan Africa and Asia, where small, voluntary schemes pooled risk at the village or cooperative level. Members paid modest premiums and received access to a basic package of primary care. CBHI was praised for its grassroots accountability and for reaching populations that formal systems ignored. But its small risk pools made it vulnerable to adverse selection and financial collapse, and it rarely covered hospital care or catastrophic expenses. Private Health Insurance, meanwhile, grew in countries where the state role was limited and individuals or employers purchased coverage from for-profit or non-profit insurers. The United States became the most prominent example, but private insurance also expanded in middle-income countries like South Africa and Brazil. Its advocates emphasized consumer choice and market efficiency; its critics pointed to high administrative costs, risk selection, and the exclusion of the poor.
Both CBHI and private insurance coexisted uneasily with the dominant tax and social insurance models. They were often framed as complementary—CBHI as a stepping-stone to formal coverage, private insurance as a supplement for those who could afford faster access. But the evidence showed that voluntary schemes, whether community-based or commercial, struggled to achieve universal coverage without strong regulation and cross-subsidies.
A more radical challenge to the established models arrived in the early 2000s. Results-Based Financing (RBF) rejected the input-based logic that had dominated health financing for decades—the assumption that paying for staff, drugs, and infrastructure would automatically produce better health. Instead, RBF tied payments to measurable outputs or outcomes: a clinic received extra funds for each fully vaccinated child, each attended delivery, or each patient who completed tuberculosis treatment. Pioneered in Rwanda, Burundi, and pilot programs across Africa, RBF was promoted by the World Bank and bilateral donors as a way to align provider incentives with health system goals.
The framework generated intense debate within the subfield. Proponents argued that RBF improved service delivery by rewarding performance and giving facilities autonomy to spend funds flexibly. Critics countered that it created perverse incentives—gaming, data manipulation, neglect of unmeasured tasks—and that its effects on health outcomes were modest and inconsistent. Rigorous evaluations, including randomized trials in Rwanda and Zambia, found that RBF increased utilization of targeted services but had limited impact on population health and sometimes widened inequities by favoring facilities in better-off areas. By the 2010s, the debate had shifted from whether RBF worked to under what conditions it could be effective, and many countries integrated performance incentives into broader financing reforms rather than adopting RBF as a standalone model.
Universal Health Coverage Financing (UHC Financing) emerged in the 2000s as an attempt to synthesize the strengths of earlier models while addressing their weaknesses. Rather than prescribing a single funding mechanism, UHC Financing defines a goal: ensuring that everyone can access needed health services without suffering financial hardship. The framework focuses on three interrelated functions—revenue raising, pooling, and purchasing—and evaluates any financing arrangement by its contribution to coverage, equity, and financial protection.
UHC Financing did not replace tax-based or social insurance models; it absorbed them as potential pathways. Countries could move toward UHC through general revenue (Thailand), social insurance (South Korea), or a combination (Ghana). The framework's distinctive contribution was to shift attention from the source of funds to the design of pooling and purchasing arrangements. Large, well-managed pools spread risk more effectively than fragmented ones; strategic purchasing—buying services based on population needs and provider performance—could improve efficiency without the narrow focus of RBF. By the 2010s, UHC had become the dominant organizing framework for health financing globally, endorsed by the World Health Organization, the World Bank, and the United Nations Sustainable Development Goals.
The most recent framework, Health Financing Transition (2010–present), addresses a problem that earlier models had largely ignored: what happens when external donor funding declines. Many low-income countries, especially in sub-Saharan Africa, had relied on development assistance for a large share of health spending—often 30–50% of total health expenditure. As economies grew and donors shifted priorities, these countries faced a financing gap that could not be filled by simply scaling up existing tax or insurance systems.
Health Financing Transition analyzes the process by which countries move from donor-dependent health financing to domestically sustainable systems. It draws attention to fiscal space—the capacity of government to raise additional revenue through taxation, borrowing, or reallocating budgets—and to the political economy of health spending. The framework also examines innovative financing mechanisms such as sin taxes on tobacco and sugar, debt swaps, and pooled procurement of medicines. In a structural sense, Health Financing Transition represents a return to the concerns that motivated Vertical Disease Control Financing—how to fund health in resource-constrained settings—but with a radically different approach: instead of project-based external funding, it emphasizes domestic ownership, progressive taxation, and the strengthening of public financial management.
Health financing today is characterized by pluralism rather than consensus. The leading frameworks—UHC Financing, Tax-Based Financing, Social Health Insurance, and Health Financing Transition—agree on several core principles: that prepayment and pooling are essential for financial protection, that voluntary schemes cannot achieve universal coverage alone, and that strategic purchasing can improve efficiency. But they disagree sharply on the best path forward. Tax-based advocates argue that only general revenue can achieve equity in countries with large informal sectors; social insurance proponents maintain that earmarked contributions create political sustainability. Health Financing Transition scholars warn that premature donor exit can destabilize fragile systems, while UHC Financing proponents emphasize that the goal should guide the choice of mechanism, not the reverse.
Meanwhile, Results-Based Financing remains a live tool in many countries, though it is now more often embedded within broader purchasing reforms than implemented as a standalone program. Community-Based Health Insurance persists in settings where formal coverage is absent, but its role is increasingly seen as transitional. Private Health Insurance continues to grow in middle-income countries, often as a parallel system for the wealthy, raising persistent equity concerns. The subfield's central challenge—how to finance health care that is both universal and sustainable—remains unresolved, but the frameworks developed over the past century provide the analytical tools to debate it rigorously.